(Q35968731)

English

Atazanavir--a once-daily HIV protease inhibitor that does not cause dyslipidemia in newly treated patients: results from two randomized clinical trials

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

1 reference

Europe PubMed Central

Atazanavir--a once-daily HIV protease inhibitor that does not cause dyslipidemia in newly treated patients: results from two randomized clinical trials (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Adriano Lazzarin

object named as

Adriano Lazzarin

8

0 references

author name string

Pedro E Cahn

1

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

José M Gatell

2

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

Kathleen Squires

3

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

Lisa D Percival

4

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

Peter J Piliero

5

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

Ian A Sanne

6

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

Sarah Shelton

7

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

Linda Odeshoo

9

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

Thomas D Kelleher

10

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

Alexandra Thiry

11

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

Michael D Giordano

12

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

Stephen M Schnittman

13

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

publication date

1 July 2004

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

Journal of the International Association of Providers of AIDS Care

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

92-98

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

The effects of antiretroviral protease inhibitors on serum lipid levels in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1177%2F154510970400300304

21 January 2018

Prospective, intensive study of metabolic changes associated with 48 weeks of amprenavir-based antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1177%2F154510970400300304

21 January 2018

Dyslipidemia in the era of HIV protease inhibitors

1 reference

https://api.crossref.org/works/10.1177%2F154510970400300304

21 January 2018

Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles?

1 reference

https://api.crossref.org/works/10.1177%2F154510970400300304

21 January 2018

Evaluation and management of dyslipidemia in patients with HIV infection

1 reference

https://api.crossref.org/works/10.1177%2F154510970400300304

21 January 2018

Nevirapine-containing antiretroviral therapy in HIV-1 infected patients results in an anti-atherogenic lipid profile

1 reference

https://api.crossref.org/works/10.1177%2F154510970400300304

21 January 2018

Myocardial infarction in HIV-infected men receiving protease inhibitors

1 reference

https://api.crossref.org/works/10.1177%2F154510970400300304

21 January 2018

Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men.

1 reference

https://api.crossref.org/works/10.1177%2F154510970400300304

21 January 2018

Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1177%2F154510970400300304

21 January 2018

Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction

1 reference

https://api.crossref.org/works/10.1177%2F154510970400300304

21 January 2018

Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection

1 reference

https://api.crossref.org/works/10.1177%2F154510970400300304

21 January 2018

Results of a phase 2 clinical trial at 48 weeks (AI424-007): a dose-ranging, safety, and efficacy comparative trial of atazanavir at three doses in combination with didanosine and stavudine in antiretroviral-naive subjects

1 reference

https://api.crossref.org/works/10.1177%2F154510970400300304

21 January 2018

Dose-ranging, randomized, clinical trial of atazanavir with lamivudine and stavudine in antiretroviral-naive subjects: 48-week results

1 reference

https://api.crossref.org/works/10.1177%2F154510970400300304

21 January 2018

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1177%2F154510970400300304

21 January 2018

Switching to zidovudine plus lamivudine plus abacavir maintains viral suppression in patients with high viral load before antiretroviral therapy: a retrospective clinical cohort analysis

1 reference

https://api.crossref.org/works/10.1177%2F154510970400300304

21 January 2018

Preliminary guidelines for the evaluation and management of dyslipidemia in adults infected with human immunodeficiency virus and receiving antiretroviral therapy: Recommendations of the Adult AIDS Clinical Trial Group Cardiovascular Disease Focus G

1 reference

https://api.crossref.org/works/10.1177%2F154510970400300304

21 January 2018

Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: recommendations of an International AIDS Society-USA panel.

1 reference

https://api.crossref.org/works/10.1177%2F154510970400300304

21 January 2018

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

https://api.crossref.org/works/10.1177%2F154510970400300304

21 January 2018

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://api.crossref.org/works/10.1177%2F154510970400300304

21 January 2018

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

1 reference

https://api.crossref.org/works/10.1177%2F154510970400300304

21 January 2018

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

1 reference

https://api.crossref.org/works/10.1177%2F154510970400300304

21 January 2018

Long-term efficacy and safety of atazanavir with stavudine and lamivudine in patients previously treated with nelfinavir or atazanavir

1 reference

https://api.crossref.org/works/10.1177%2F154510970400300304

21 January 2018

Hyperlipidemia associated with HIV protease inhibitor use: pathophysiology, prevalence, risk factors and treatment

1 reference

https://api.crossref.org/works/10.1177%2F154510970400300304

21 January 2018

A review of low-dose ritonavir in protease inhibitor combination therapy

1 reference

https://api.crossref.org/works/10.1177%2F154510970400300304

21 January 2018

Incidence of hyperlipidaemia in a cohort of 212 HIV-infected patients receiving a protease inhibitor-based antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1177%2F154510970400300304

21 January 2018

Therapy with atazanavir plus saquinavir in patients failing highly active antiretroviral therapy: a randomized comparative pilot trial

1 reference

https://api.crossref.org/works/10.1177%2F154510970400300304

21 January 2018

Protease inhibitors and cardiovascular outcomes in patients with HIV-1

1 reference

https://api.crossref.org/works/10.1177%2F154510970400300304

21 January 2018

Guidelines for the Evaluation and Management of Dyslipidemia in Human Immunodeficiency Virus (HIV)-Infected Adults Receiving Antiretroviral Therapy: Recommendations of the HIV Medicine Association of the Infectious Disease Society of America and the

1 reference

https://api.crossref.org/works/10.1177%2F154510970400300304

21 January 2018

Identifiers

10.1177/154510970400300304

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35968731&oldid=1609508193"